On Wednesday, the FDA announced that the drug tirzepatide, which is currently available for Type 2 diabetes patients as "Mounjaro" is now approved to treat obesity and overweight, too
It is the leading cause of liver transplant waitlist additions
Medical Evaluation and Program Enrollment Enrollment in the GLP-1 Medical Weight Management Program includes a comprehensive medical evaluation to ensure patient safety and treatment suitability
At all relevant times, Defendants knew, or in the exercise of reasonable care, should have known that the use of Ozempic could cause Plaintiffs injuries and, thus, created a dangerous and unreasonable risk of injury to Plaintiff and other users of this product for which Defendants did not warn, the lawsuit states
Sobo Approaches Muscle-Preserving Medical Weight Loss Dr
How do I reconstitute a 5 mg semaglutide vial